Hydrokortyzon Allefin

Hydrocortisone Acetate, the active ingredient in Hydrokortyzon Allefin, is a corticosteroid presented as a topical formulation for skin application. It treats inflammatory skin conditions such as eczema, dermatitis and psoriasis in adults and children.

GNH USA supplies Hydrokortyzon Allefin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydrocortisone Acetate is used to manage inflammatory skin disorders by reducing local inflammation.

Eczema: reduces redness, itching and swelling. Dermatitis: alleviates symptoms and promotes healing. Psoriasis: decreases plaque formation and inflammation. Other inflammatory skin conditions: provides symptomatic relief.

Topical hydrocortisone acetate can cause a range of local and systemic reactions.

Common Side Effects: - Skin irritation or burning sensation at the application site. - Pruritus or mild itching. - Dryness or peeling of the treated skin. - Folliculitis or acne‑like eruptions. - Mild erythema.

Serious or Rare Side Effects: - Allergic contact dermatitis with severe redness and swelling. - Skin atrophy or thinning with prolonged use. - Hypopigmentation of the treated area. - Systemic absorption leading to adrenal suppression. - Secondary bacterial or fungal infection of the skin. - Anaphylactic reaction in highly sensitised individuals.

Use hydrocortisone acetate with attention to patient‑specific factors and application conditions.

Pregnancy: safety not established; use only if benefit outweighs risk. Breastfeeding: unknown; consider potential exposure to infant. Age: apply cautiously in children; monitor for systemic effects. Application area: avoid extensive use on large body surfaces or broken skin to limit systemic absorption. Concurrent infection: do not apply to infected skin without medical advice. Store at room temperature: keep in original container, protect from moisture and light.

Topical hydrocortisone acetate may interact with other systemic or topical agents, altering efficacy or safety.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Potent CYP3A4 inhibitors: may raise systemic exposure from skin absorption. - Live vaccines: topical steroids can diminish immune response.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., azoles): may increase local irritation. - Antibiotic ointments: may alter normal skin flora and affect healing. - Other topical immunosuppressants: combined use may enhance immunosuppression.